Exane Derivatives’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $75.6K | Buy |
287
+161
| +128% | +$42.4K | 0.04% | 285 |
|
|
2022
Q1 | $30.2K | Buy |
126
+124
| +6,200% | +$29.7K | 0.01% | 626 |
|
|
2021
Q4 | $459 | Sell |
2
-5,649
| -100% | -$1.3M | ﹤0.01% | 764 |
|
|
2021
Q3 | $1.13M | Sell |
5,651
-6
| -0.1% | -$1.2K | 0.27% | 73 |
|
|
2021
Q2 | $1.33M | Buy |
5,657
+11
| +0.2% | +$2.59K | 0.3% | 69 |
|
|
2021
Q1 | $1.36M | Sell |
5,646
-176
| -3% | -$42.5K | 0.39% | 53 |
|
|
2020
Q4 | $1.21M | Buy |
5,822
+5,626
| +2,870% | +$1.17M | 0.36% | 54 |
|
|
2020
Q3 | $33.2K | Sell |
196
-478
| -71% | -$81K | 0.01% | 378 |
|
|
2020
Q2 | $126K | Sell |
674
-27
| -4% | -$5.07K | 0.03% | 244 |
|
|
2020
Q1 | $124K | Buy |
701
+456
| +186% | +$80.8K | 0.03% | 239 |
|
|
2019
Q4 | $51K | Sell |
245
-1,680
| -87% | -$350K | 0.01% | 343 |
|
|
2019
Q3 | $292K | Sell |
1,925
-1,300
| -40% | -$197K | 0.05% | 191 |
|
|
2019
Q2 | $508K | Buy |
3,225
+1,938
| +151% | +$305K | 0.09% | 160 |
|
|
2019
Q1 | $207K | Buy |
1,287
+870
| +209% | +$140K | 0.04% | 204 |
|
|
2018
Q4 | $79.2K | Sell |
417
-16,663
| -98% | -$3.16M | 0.01% | 313 |
|
|
2018
Q3 | $3.56M | Buy |
17,080
+3,735
| +28% | +$778K | 0.67% | 30 |
|
|
2018
Q2 | $2.27M | Buy |
+13,345
| New | +$2.27M | 0.38% | 53 |
|